| Value | ₹0.01 Cr |
|---|
BSE filing, BSE: 542910. Summary written from the filing by ALFA Finder's alert engine.
Valencia Nutrition Ltd: key numbers
- Share price
- ₹52.80
- Market cap
- ₹104.8 Cr
- Revenue (annual)
- ₹7.88 Cr
- Net profit (annual)
- ₹1.09 Cr
- P/E (TTM)
- 95.9×Sector 26.2×
- Promoter holding
- 66.92%+2.74% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Valencia Nutrition Ltd
All →Valencia Nutrition Convertible Warrants
Valencia Nutrition Ltd reported the lapse of 23,90,000 convertible warrants following the expiry of the conversion period. An upfront amount of ₹2.39 Crore was forfeited.
- Value
- ₹2.39 Cr
Valencia Nutrition Other Announcement
Valencia Nutrition Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Valencia Nutrition Other Announcement
Valencia Nutrition Ltd directors and relatives disclosed multiple market transactions. Hiren Rajendra Jain and Parthavi Hiren Jain purchased shares, while Jay Jatin Shah sold equity.
- Value
- ₹0.39 Cr
Valencia Nutrition Other Announcement
Mr. Jay Jatin Shah, WTD & CFO of Valencia Nutrition Limited, disposed of 42,000 equity shares via open market transactions totaling Rs. 0.18 Crore.
- Value
- ₹0.25 Cr
Valencia Nutrition Other Announcement
Director Jay Jatin Shah sold 18,000 shares, while Director Ashish Kamdar and his relative bought 18,000 shares combined. These insider trades were reported via Reg 7(2).
- Value
- ₹0.22 Cr
Valencia Nutrition Annual General Meeting
Valencia Nutrition Limited held its 13th Annual General Meeting on September 29, 2026. Shareholders considered financial adoption, director appointments, and resolutions regarding slump sales and related party transactions.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr